chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician's assistant and physician concerning a 1 year old male who on 08/28/01 was vaccinated with varicella virus vaccine live. Concomitant vaccination on 08/28/2001 included streptococcus pneumonia vaccine (Prevnar). The physician's assistant reported the both vaccinations were received in one leg. Subsequently, the patient developed an injection site reaction: rash, papular lesion. The patient was seen on 09/07/2001. In follow-up, the physician reported that the "local vesicular reactions " were 'not atypical or adverse". It was noted that two other patients (WAES010192071 & 01091393) had similar experiences following exposure to varicella virus vaccine live. No further information is available.
Patient complained about Headache lasted for several hours, joint pain that lasted until he went to bed, and injection site pain.
got both shots. Then a few months later got shingles/suspected vaccination failure; got shingles in his right arm.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, several months after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: This case was reported by patient's wife. The age at vaccination was not reported. The patient got both shingles shots and then a few months later got shingles in his right arm. This case was considered as suspected vaccination failure since the details regarding laboratory test confirming shingles were unknown at the time of reporting.
57 y/o female w/ a complaint of left arm pain. She received a PCV13 vaccination 5 days ago, the day after she felt induration at the injection site.
Arms, legs, back, no new meds or OTCs. On Bactrim for months, Atripla for months. Had sun distribution. Stopped Bactrim, but it worsened. Refused to stop Atripla but it improved off it.
After first vaccine, he had 36 hours of fatigue, slept a lot, and no appetite.
boostrix expired 28JAN2022, administred 27JUL2022; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 66-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 374LV, expiry date 28th June 2022) for prophylaxis.   On 27th July 2022, the patient received Boostrix. On 27th July 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 27-Jul-2022 Reporter's comment: The health care professional reported that on the day of reporting an expired dose of Boostrix was administered. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow-up via phone. Additional supportive information: The patient received an expired dose of Boostrix, which led to expired vaccine used.
Painful for a week, Red, Swelling, and warm to touch of the entire upper arm for 3 weeks, with continued soreness 4 weeks later. no treatment pt was out of state from doctor, no outcome
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 63-year-old male patient received BNT162b2 (BNT162B2), in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 63 years for covid-19 immunisation. The patient's relevant medical history included: "diabetes" (unspecified if ongoing); "hypertension" (unspecified if ongoing); "increased cholesterol" (unspecified if ongoing). Concomitant medication(s) included: SIMVASTATIN, start date: Jan2006, stop date: 10May2022. Vaccination history included: Covid-19 vaccine (Dose 1, Single), administration date: Feb2021, for Covid-19 immunisation; Covid-19 vaccine (Dose 2, Single), administration date: Mar2021, for Covid-19 immunisation. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information in the case, an association between the reported event and the suspect product BNT162B2 cannot be ruled out.
About 3 to 4 weeks after dosage I developed ringing in the ears = tinnitus
1st dose on 21Oct2020, 2nd not received; This case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (Received 1st dose of Shingrix on 21st October 2020 (batch number:2ZN2D and expiry date:16th September 2022)).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 03-NOV-2022 Reporter's Comment: The reporter declined to provide patient details. The reporter reported that, the patient had not yet received second dose of Shingrix.  The reporter gave permission to follow-up via email. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The VAERS provided corresponded to the 1st dose of Shingrix as 2nd dose was not received.
Felt like tongue was swelling. EMS evaluated.   Given 10more minutes to wait instructed  if gets worse to go to ER. Can take benadryl. If uses epi pen need to go to ER. Hx of having in past.
Headache, Myalgia, Fever, Diarrhea, NauseaVomiting, chills and fatigue Narrative:   Other Relevant History:
My son has had a constant fever since 11/08/21, Monday night. Fever was 102.6. He was not able to sleep during the night. Fever came down to 102.0 with Tylenol. After six hours, I have him Motrin and his fever stayed between 102.3 and 101.0. He had fever readings within that range throughout the day. On 11/09/21 at 7pm, gave him Motrin again.  On 11/09/21 he went to bed with a  temperature of 99.5.
103.7 fever at 2am. Extreme shaking for 2 hours and temp jumped up to 106.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.    Co-suspect product included non-company product INFLUENZA VACCINE INACT SPLIT 4V (FLUARIX QUADRIVALENT) for an unknown indication.    No Medical History information was reported.   On 18-Oct-2021, the patient received first dose of INFLUENZA VACCINE INACT SPLIT 4V (FLUARIX QUADRIVALENT) (Intramuscular) 1 dosage form. On 18-Oct-2021 at 11:50 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Oct-2021 at 11:50 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Oct-2021 at 11:50 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment details were reported.
Warm to touch around injection site after 2nd dose; Swelling around injection site after 2nd dose; Redness around injection site after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch around injection site after 2nd dose), VACCINATION SITE SWELLING (Swelling around injection site after 2nd dose) and VACCINATION SITE ERYTHEMA (Redness around injection site after 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch around injection site after 2nd dose), VACCINATION SITE SWELLING (Swelling around injection site after 2nd dose) and VACCINATION SITE ERYTHEMA (Redness around injection site after 2nd dose). At the time of the report, VACCINATION SITE WARMTH (Warm to touch around injection site after 2nd dose) and VACCINATION SITE ERYTHEMA (Redness around injection site after 2nd dose) outcome was unknown and VACCINATION SITE SWELLING (Swelling around injection site after 2nd dose) was resolving.            No concomitant medication information was provided.  No treatment information was provided.
Symptoms started at 5am (Friday)the day following vaccination. Symptoms included body ache, severe headache, chills, shivering, and sweating.  The symptoms disappeared around 6am (Saturday) the day after symptoms started. No treatment given.
Patient said she did not lie down for several hours after receiving shot. When she did and got back up to watch TV, her vision was blurry and unable to focus. Her vision returned to normal shortly. (As told by patient to Pharm.D. on 10/13/16).
Initial and follow-up information has been received from a physician and a phone call to a medical assistant, concerning a 19 year old male patient with environmental allergies (cats) and no known relevant medical history, who on 17-AUG-2010 was vaccinated with the first dose of GARDASIL (lot # 666163/0664Z), intramuscularly and then a dose of VARIVAX (lot # 665912/1772Y, route not provided) and fainted. After the patient fainted he started to have a seizure, which was reported as having "jerking" movements, within a minute of receiving GARDASIL in the physician's office. No laboratory test was performed. The patient recovered before leaving the physician's office on 17-AUG-2010. The events were considered to be other important medical events by the physician. No further information is available.
Given vaccines by myself.  When walking down hall a couple minutes later, complained of itching.  Brought back to exam room.  Covered in confluent hives, eyes and ears puffy.  Benadryl given.  Oz Sat 95%, RA briefly then 99% RA.  Never wheeze.  A few coughs after receiving Benadryl resolved.  Taken via EMS to hospital ED, where received steroids, Epi pen Jr, monitored.  Discharged home with 5 day course of steroids.
Received flu vaccine and Tdap on same day - reports soreness at Tdap injection site for a couple days but has had shoulder stiffness since then. Denies redness, edema, numbness or tingling in arm just stiff and tired at end of day especially when raising arm above head.
Patient given dose of Pfizer as booster shot when the dose was later found to be drawn up on 01/19/2021.  Dose was stored in refrigerator overnight still in vial. Patient called and alerted of above information.
Body started to break out in sever hives 3 hours after receiving shot. Went to ER and Benadryl with a steroid was given. Hives then slowly went away. 8 hours later, hives flared up again. Returned to ER and doctors prescribed 50mg of Benadryl. Took 2 pills over 5 hours yet hives worsened and spread to face and neck with skin hot to the touch. Returned to ER where IV fluids, liquid Benadryl and liquid steroid was administered, no body temperature spike. Released from ER 2 hours later with hives still present and skin hot to the touch. Still ongoing with hives and hot skin.
Patient developed a quarter size rash around the injection site. The rash is pink in color and painful.
Severe inflammation, colon inflammation with severe diarrhea for months, head pain and pressure, severe facial and neck pain, vertigo, long Covid worsened
Obviously this is anecdotal, I have not received medical treatment and am relating as best as I can.  I got a first Moderna vaccine on the morning of Wednesday, September 15.  I have a history of experiencing headaches and "brain fog" but nothing crippling.  Starting in the evening and continuing for Thursday, Friday, and Saturday I had a pounding headache on the right side and in the middle of my head - this was qualitatively different than my usual chronic headaches.  it was constant but the pressure kept changing, I felt as though I might have been sensitive to circulation in my head.  I was ready to check into a hospital and was reading and rereading vaccine side-effects out of concern.  I spent Thursday and Friday flat on my back, and tried to do as little as possible on Saturday, and Saturday night when I tried to participate in a dinner conversation I experienced such brain-fog that I'm amazed that I could function at all.  Yesterday (Sunday) I was mostly back to normal.  At some times during my headache my pulse was about 100 to 105.  My arm was sore but not red or swollen.   I understand that the reaction to a second dose is often worse.  Since I have do experience chronic headaches and mind fog (though not anything like what I experienced the past several days), and since I'm in otherwise OK health, and since I've already received a dose of the Moderna vaccine, I wonder if a second presents more risk for me than the advantages it offers?  Of course I don't want to get COVID and COVID can be crippling even to a healthy person, but since I don't have underlying conditions and I've I've already received one dose, perhaps I should not get a second dose?  I'm extremely concerned about undergoing any similar crippling headache.  Please advise if a second dose is contraindicated.
Pt recvd vax 9DEC91 & on 10DEC91 had rash on face spreading to rest of body achy joints & fever; @ 2300 taken to hosp because of swelling of eyes, fingers & feet; admitted to ICU for over night;
The c/o of syncope and urinary incontinence; The c/o of syncope and urinary incontinence.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (The c/o of syncope and urinary incontinence) and URINARY INCONTINENCE (The c/o of syncope and urinary incontinence.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SYNCOPE (The c/o of syncope and urinary incontinence) (seriousness criterion medically significant) and URINARY INCONTINENCE (The c/o of syncope and urinary incontinence.) (seriousness criterion medically significant). At the time of the report, SYNCOPE (The c/o of syncope and urinary incontinence) and URINARY INCONTINENCE (The c/o of syncope and urinary incontinence.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment information was not provided by reporter.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I received an infusion of Ocrevus with administration of IV Benadryl, oral Tylenol and IV Solumedrol on 1-7-2022. I noticed pain to my left arm that same evening. Three and 1/2 months prior to this infusion, I had received vaccination of 3rd dose vaccine. I started having left arm pain, redness, warmth and swelling. Since I am a physician, I ordered an ultrasound of left upper extremity Jan 11th, 2022 and it showed a venous thrombosis. I started taking Xarelto and it is now down to 20mg. The redness went down within a week. The swelling improved to almost normal approx. one month ago. The pain improved around the middle of March. I done a repeat ultrasound 1 week later and it was not growing. It did find the thrombosis was decreasing in size. I am feeling better now with symptoms resolved.
experienced chills after the 2nd shot; This is a spontaneous report from a contactable consumer.  A female patient (wife) of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 30Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. The patient experienced chills (Jan2021) after the 2nd shot yesterday on 30Jan2021. The outcome of the events was unknown.   Information on the Lot/Batch number has been requested.
had tetanus shot & devel itchiness, swelling & had some discoloration; last time had a tetanus shot had local soreness; pt has been treated w/DPh & amoxicillin;
Pt got out of his truck and walked across his yard. He got dizzy and fell to the ground. He was out for 15 min.  He had numbness in his face and lips.  he had a headache and vomited 3 - 4 times.
pt recv vax & p/36hr devel urticaria in both upper & lower extremities, face, chest & abd;no h/o diff of breathing given atarax;
Patient reports to clinic with redness and swelling with pruritis on medial side of left arm.
Pt recv vax on 8/14/98; on 8/24/98 pt became ill; on 8/28/ pt exp light stools, dark urine, and jaundice.  Pt saw M.D. on 9/4/98.
Client returned to the Clinic for Dose #2 of Moderna Covid-19 vaccine on 02/04/21.  When reviewing information regarding how Client did with dose #1, on 12/31/2020 at the Clinic, she stated she had pain and difficulty with movement of right arm after receiving dose #1.  Stated it was better, but still having issues with rt. arm. She stated no other issues besides this with dose #1. She stated she saw her PCP and was going to have an MRI the following week.   States her PCP recommended still receiving dose #2 as he did not believe it was related to the vaccine itself.  Dose #2 was given in the left arm.
Headache. Dizzy. Itching on right side. Rash on right cheek. Aching In upper back right side. Erratic racing pulse.
Arm Soreness; Shoulder Soreness; A spontaneous report was received from a consumer concerning a male  patient who received Moderna's Covid 19 vaccine  and developed arm soreness and shoulder soreness. The patient's medical history and lab datas were not provided.  Concomitant product used was not provided .     The patient received his first dose of mRNA-1273 (Batch number:  013L20A), intramuscularly on 13-JAN-2021. On 15-JAN-2021, the patient developed arm soreness and shoulder soreness.The patient told that he is hypochondriac and didn't want to disclose his details.  He also stated that two of his co-workers were also experiencing exactly the same AEs but didn't want to share/disclose their names.  Treatment information was unknown.    Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events were unknown.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient's medical history included rheumatoid arthritis. On 07-OCT-2016, the patient was vaccinated with ZOSTAVAX, subcutaneously (dose, site of administration, lot # and expiry date were not reported). Concomitant medications included unspecified disease-modifying antirheumatic drugs. In approximately October 2016, reported as within 24 hours, the injection site became red, had swelling and was hot to touch. There was no treatment given for the adverse events. The outcome of the events was reported as not recovered. The patient visited the pharmacy to seek medical attention. The relatedness between the events and ZOSTAVAX was not provided. Additional information has been requested.
Patient went from being a very healthy, active, goal oriented student to feeling tired and sick all the time. Two weeks after the first dose she had a severe sore throat which lasted for weeks and she was in extreme pain and had to take Tylenol with Codeine and felt tired and weak all the time.   After the second dose she also started to experience anxiety because she was concerned that something was wrong with her.  After the third dose she has had several things happen.  She began breaking out with a small pimple like lesion on her face which turned into a dime size open wound which looked like a burn.  To this day she still gets one a month and they are all leaving scars on her face.  She has been to a dermatologist and to her pediatrician and no one has an answer as to what they are or where she is getting them from.  The end of August she began feeling depressed because she never feels well and she lost 18 pounds in 4 weeks time.  She went down to 88 pounds.  Her legs are bruising terribly and she has been to the doctor's twice and no answers.  Her CBC's were all WNL. I was afraid she was suffering from Anorexia, however, since then she has gained the 20 pounds back in a four week period of time which seems very unusual in such a short period of time.  She states that ever since she has had the second dose of the vaccine she always feels scattered whereas in the past she was always so focused.